284 related articles for article (PubMed ID: 3885180)
1. Primary immunization with diphtheria-tetanus toxoids vaccine and diphtheria-tetanus toxoids-pertussis vaccine adsorbed: comparison of schedules.
Barkin RM; Samuelson JS; Gotlin LP; Barkin SZ
Pediatr Infect Dis; 1985; 4(2):168-71. PubMed ID: 3885180
[TBL] [Abstract][Full Text] [Related]
2. Diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule.
Barkin RM; Samuelson JS; Gotlin LP
Dev Biol Stand; 1985; 61():297-307. PubMed ID: 2872117
[TBL] [Abstract][Full Text] [Related]
3. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series.
Pichichero ME; Barkin RM; Samuelson JS
Pediatr Infect Dis; 1986; 5(4):428-30. PubMed ID: 3487779
[TBL] [Abstract][Full Text] [Related]
4. Estimated effects of a delay in the recommended vaccination schedule for diphtheria and tetanus toxoids and pertussis vaccine.
Funkhouser AW; Wassilak SG; Orenstein WA; Hinman AR; Mortimer EA
JAMA; 1987 Mar; 257(10):1341-6. PubMed ID: 3493356
[TBL] [Abstract][Full Text] [Related]
5. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children.
Pichichero ME; Badgett JT; Rodgers GC; McLinn S; Trevino-Scatterday B; Nelson JD
Pediatr Infect Dis J; 1987 Apr; 6(4):352-63. PubMed ID: 3495775
[TBL] [Abstract][Full Text] [Related]
6. DTP reactions and serologic response with a reduced dose schedule.
Barkin RM; Samuelson JS; Gotlin LP
J Pediatr; 1984 Aug; 105(2):189-94. PubMed ID: 6747752
[TBL] [Abstract][Full Text] [Related]
7. DTP vaccine.
Barkin RM; Samuelson JS
JAMA; 1986 Apr; 255(15):2026-7. PubMed ID: 3485728
[No Abstract] [Full Text] [Related]
8. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
Bernbaum J; Daft A; Samuelson J; Polin RA
Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
[TBL] [Abstract][Full Text] [Related]
9. Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.
Taranger J; Trollfors B; Knutsson N
Dev Biol Stand; 1997; 89():109-12. PubMed ID: 9272340
[TBL] [Abstract][Full Text] [Related]
10. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled trial of a pertussis-toxoid vaccine.
Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children.
Marcinak JF; Ward M; Frank AL; Boyer KM; Froeschle JE; Hosbach PH
Am J Dis Child; 1993 Mar; 147(3):290-4. PubMed ID: 8438810
[TBL] [Abstract][Full Text] [Related]
13. Two injections of diphtheria-tetanus-pertussis-polio vaccine as the backbone of a simplified immunization schedule in developing countries.
Cohen H; Nagel J
Rev Infect Dis; 1984; 6 Suppl 2():S350-1. PubMed ID: 6610910
[TBL] [Abstract][Full Text] [Related]
14. [Reactogenic properties of a DTP vaccine with a reduced antigen dosage].
Baeva EA; Selezneva TS; Kucherovskaia TV; Auzinia AV; Glinskaia EV
Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):47-50. PubMed ID: 2879401
[TBL] [Abstract][Full Text] [Related]
15. Response of preterm infants to diphtheria-tetanus-pertussis immunizations.
Bernbaum JC; Daft A; Anolik R; Samuelson J; Barkin R; Douglas S; Polin R
J Pediatr; 1985 Aug; 107(2):184-8. PubMed ID: 3874942
[TBL] [Abstract][Full Text] [Related]
16. New recommended schedule for active immunization of normal infants and children.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Sep; 35(37):577-9. PubMed ID: 3092014
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
[TBL] [Abstract][Full Text] [Related]
18. Leads from the MMWR. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
JAMA; 1985 Aug 23-30; 254(8):1009-11, 1014-6. PubMed ID: 3874970
[No Abstract] [Full Text] [Related]
19. Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
Schmitt-Grohé S; Stehr K; Cherry JD; Heininger U; Uberall MA; Laussucq S; Eckhardt T
Dev Biol Stand; 1997; 89():113-8. PubMed ID: 9272341
[TBL] [Abstract][Full Text] [Related]
20. Pertussis immunization of infants using a new combined DTP-polio vaccine.
Drucker J; Schatzmayr H; Grenier B; Ajjan N; Peyron L; Roumiantzeff M
Dev Biol Stand; 1985; 61():309-13. PubMed ID: 2872119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
